Holen Sie sich die Stockscreener-App
0.1809
28.84%
-0.0733
Schlusskurs vom Vortag:
$0.2542
Offen:
$0.1839
24-Stunden-Volumen:
14.43M
Relative Volume:
3.06
Marktkapitalisierung:
$843.04K
Einnahmen:
$75,000
Nettoeinkommen (Verlust:
$-42.41M
KGV:
-0.00101
EPS:
-179.8206
Netto-Cashflow:
$-18.47M
1W Leistung:
-33.57%
1M Leistung:
-58.55%
6M Leistung:
-97.86%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.1706
$0.1979
1-Wochen-Bereich:
$0.1706
$0.2699
52-Wochen-Spanne:
$0.1706
$166.50
Profusa Inc Stock (PFSA) Company Profile
Firmenname
Profusa Inc
Sektor
Branche
Telefon
212-494-9022
Adresse
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Compare PFSA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.1809 | 843.04K | 75,000 | -42.41M | -18.47M | -179.82 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profusa Inc Aktie (PFSA) Neueste Nachrichten
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Profusa submits response to European regulator for device approval - Investing.com UK
Profusa submits response to European regulator for device approval By Investing.com - Investing.com Canada
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform - The Manila Times
Profusa Submits Response Package to GMED as Part of Ongoing Ce Mark Review Process for Lumee Oxygen Platform - marketscreener.com
Profusa CEO urges shareholders to vote on Nasdaq listing proposals By Investing.com - Investing.com Nigeria
Profusa CEO urges shareholders to vote on Nasdaq listing proposals - Investing.com
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting - The Manila Times
Profusa Issues Letter to Shareholders Encouraging - GlobeNewswire
Profusa, Inc. Files 8-K: Advance Notice for Common Stock Purchase Under Equity Line Agreement with Ascent Partners, Nasdaq Listed (PFSA) - Minichart
Profusa (NASDAQ: PFSA) registers 179.3M shares; Ascent holds majority - Stock Titan
Profusa Taps Equity Line With Dilutive True-Up Mechanism - TipRanks
Profusa secures temporary equity purchase terms with Ascent under amended SPA - TradingView
Profusa (PFSA) adjusts Ascent equity line with caps, VWAP and true-up terms - Stock Titan
Profusa (PFSA) affiliates report 9.99% ownership; reorg adds Eagle Claw - Stock Titan
Profusa to acquire multi-omics platform, partners with Mayo Clinic - Investing.com
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Inc. (PFSA) Slips 3.56% as Stock Approaches Key Support at $0.33Fibonacci Arc - The Legal Advocate
Profusa Shares Below 40 Cents as Nasdaq Deadline Nears - Bez Kabli
Profusa Inc. (PFSA) Slides 4.7% as Stock Tests Key Support at $0.33Ending Diagonal - newsline.com
Profusa Inc. (PFSA) Facing Resistance at $0.38 as Shares Dip 3.21%Volume Breakout Ideas - newsline.com
PFSA | Profusa, Inc. Common Stock Executive Compensation - Quiver Quantitative
[ARS] Profusa, Inc. SEC Filing - Stock Titan
Profusa (NASDAQ: PFSA) eyes major reverse split, $30M PanOmics stock acquisition and note conversion - Stock Titan
Profusa Amends PanOmics Acquisition Terms to Reduce Dilution - TipRanks
Profusa Amends $30 Million Asset Purchase of PanOmics Assay, Drops 12% Management Equity Grant - TradingView
[8-K] Profusa, Inc. Reports Material Event - Stock Titan
Profusa Inc. (PFSA) Edges Higher, Testing Key Resistance at $0.40Low Volatility Picks - The Legal Advocate
PFSA Should I Buy - Intellectia AI
Profusa, Inc. Submits Advance Notice for Equity Line Share Purchase with Ascent Partners Fund LLC – SEC Filing 8-K May 18, 2026 - Minichart
Profusa submits equity purchase notice to Ascent Partners under credit agreement - Investing.com Nigeria
Profusa (NASDAQ: PFSA) registers 179.3M resale shares; Ascent equity line terms detailed - Stock Titan
Profusa Taps Equity Line for Near-Term Liquidity - TipRanks
Profusa submits advance notice to Ascent for up to 9.99% equity purchase with true-up mechanism - TradingView
Profusa (NASDAQ: PFSA) details May equity line share purchase terms - Stock Titan
Number of shareholders of Profusa, Inc. – NASDAQ:PFSA - TradingView
Profusa Transfers Nasdaq Listing Amid Ongoing Compliance Uncertainty - The Globe and Mail
PFSA Financials: Income Statement, Balance Sheet & Cash Flow | Profusa Inc - Stock Titan
Profusa, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Profusa (NASDAQ: PFSA) Q1 2026 loss deepens amid going concern and Nasdaq listing pressure - Stock Titan
Profusa, Inc. Announces Transfer to Nasdaq Capital Market to Ensure Continued Listing Compliance - Minichart
Profusa to Transfer Listing to The Nasdaq Capital Market Effective May 15, 2026 - TradingView
Profusa (Nasdaq: PFSA) shifts stock listing to Nasdaq Capital Market tier - Stock Titan
Profusa moves to Nasdaq Capital Market amid compliance efforts By Investing.com - Investing.com Australia
Profusa moves to Nasdaq Capital Market amid compliance efforts - Investing.com
Profusa Announces Listing Transfer to The Nasdaq Capital Market - The Manila Times
Profusa announces listing transfer to the Nasdaq Capital Market - marketscreener.com
Digital health company Profusa shifts Nasdaq tier to meet listing rules - Stock Titan
Profusa granted transfer to Nasdaq Capital Market, faces July compliance deadline - MSN
Finanzdaten der Profusa Inc-Aktie (PFSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):